<DOC>
	<DOCNO>NCT00139009</DOCNO>
	<brief_summary>The primary objective investigate intralymphocyte concentration CsA renal heart transplant recipient elucidate association intracellular concentration efficacy ( rejection episodes histology ) transplant patient CsA base immunosuppressive therapy .</brief_summary>
	<brief_title>Intracellular Renal/Myocardial Tissue Concentrations Cyclosporine A ( CsA ) Rejection Frequency Following Transplantation</brief_title>
	<detailed_description>The primary objective investigate intralymphocyte concentration CsA renal heart transplant recipient elucidate association intracellular concentration efficacy ( rejection episodes histology ) transplant patient CsA base immunosuppressive therapy . Secondary objective investigate association intralymphocyte concentration whole-blood concentration CsA , renal tissue concentration nephrotoxicity , heart tissue concentration cardiotoxicity CsA base immunosuppressive therapy transplant patient . In addition , study aim validate use quinine probe determination CYP3A4 activity transplant patient well proteomic-based urine analysis screen tool acute rejection episode transplant patient .</detailed_description>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>1 . Renal heart transplant recipient schedule receive CsA part immunosuppressive therapy time transplantation . 2 . 18 year age old . 3 . Signed informed consent . 1 . Known contraindication renal heart biopsy , respectively , time inclusion . 2 . Concomitant treatment : diltiazem , verapamil , phenytoin , carbamazepine , fluconazole , ketoconazole , erythromycin , clarithromycin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>intracellular concentration</keyword>
	<keyword>cyclosporine A</keyword>
	<keyword>renal biopsy</keyword>
	<keyword>heart biopsy</keyword>
	<keyword>Renal transplant recipient</keyword>
</DOC>